Brigham and Women's Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Brigham and Women's Hospital sits in the top decile of US sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count).
Brigham and Women's Hospital: 937 sponsored US clinical trials, 145 recruiting.
Brigham and Women's Hospital sponsors 937 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 608 completed. 124 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.
Top-decile sponsor footprint
Brigham and Women's Hospital ranks in the top decile of sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
608 of 677 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
937 total, page 11 of 19
Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection
NCT02733029
Gabapentin Regimens and Their Effects on Opioid Consumption
NCT03334903
Angiogenic Imaging in Pulmonary Arterial Hypertension
NCT03166306
Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban
NCT03326063
Virtual Visits at Brigham and Women's Hospital
NCT03592355
Prediction of Outcomes Following Total Knee Replacement- Pilot
NCT04328701
A Positive Psychology Intervention for Patients With Multiple Sclerosis
NCT03637699
Interaction of Melatonin With MTNR1B Genotype on Glucose Control - Study 2
NCT03464084
Potatoes, Hypertension RIsk and Endothelial Function Study
NCT03116919
Comparing Different Types of Physical Therapy for Treating People With a Meniscal Tear and Osteoarthritis
NCT03059004
Brief Title: Project 4 Example: Mixed Hybrid Checklist
NCT05272163
Fetal Pillow Randomized Controlled Trial
NCT03342508
Adapting Sleep and Yoga Interventions for Maximal Effectiveness in Low Income Populations
NCT03392194
DAW1033D in Obstructive Sleep Apnea
NCT03383887
Supraclavicular Block vs Retroclavicular Block: Incidence of Phrenic Nerve Paralysis
NCT02631122
Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief
NCT02995733
Novel Strategies to Improve Immunomodulation and Non-invasive Clinical Monitoring in VCA
NCT03241719
Excess Opioid Disposal Following Orthopedic Foot and Ankle Surgery
NCT03285061
Hypoglycemia and Autonomic Nervous System Function- B2
NCT03422471
Replication of the LEADER Diabetes Trial in Healthcare Claims
NCT03936049
Replication of the ONTARGET Antihypertensive Trial in Healthcare Claims Data
NCT04354350
Replication of the CARMELINA Diabetes Trial in Healthcare Claims
NCT03936036
Replication of the TRANSCEND Antihypertensive Trial in Healthcare Claims Data
NCT04354376
Replication of the SAVOR-TIMI Diabetes Trial in Healthcare Claims
NCT03936023
Replication of the TECOS Diabetes Trial in Healthcare Claims
NCT03936062
Replication of the CANVAS Diabetes Trial in Healthcare Claims
NCT03936010
DAW1033B2 in Obstructive Sleep Apnea
NCT03426631
Somatotopic Configuration of Distal Residual Limb Tissues in Lower Extremity Amputations
NCT03374319
Short-Term Endogenous Hydrogen Sulfide Upregulation
NCT03303534
Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea
NCT03189173
Rotational Thromboelastometry for the Transfusion Management of Postpartum Hemorrhage After Vaginal or Cesarean Delivery
NCT03064152
Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD
NCT02228408
Enabling Personalized Medicine Through Exome Sequencing in the U.S. Air Force
NCT03276637
Home-Based Exercise Program For Recovery After Transcatheter Aortic Valve Replacement
NCT02805309
Motivational Interview Intervention to Help Patients Formulate Their Goals for Medical Care in the Emergency Department
NCT03208530
The ICON Study: Outcomes After FMT for Patients With IBD and CDI
NCT03106844
Menopausal Sleep Fragmentation and Body Fat Gain
NCT03047330
Measurement of Renal Functional Reserve
NCT03190070
Validation of Novel Predictive Score for Patients With Spinal Metastases
NCT03224650
Acute Kidney Injury Standardized Clinical Assessment and Management Plan for Renal Replacement Initiation
NCT03368183
Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis
NCT03138525
Post-Acute Physician Home Visit Program
NCT03178513
Pediatric Adenotonsillectomy Trial for Snoring
NCT02562040
Hospital-Level Care at Home for Acutely Ill Adults
NCT03203759
Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure
NCT03083886
Prediction of 30-Day Readmission Using Machine Learning
NCT04849312
Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia
NCT03034018
Determine the Most Effective Intervention for Hemorrhage Control Readiness for Laypersons: The PATTS Trial
NCT03479112
Informed Implementation of Breast Density Reporting
NCT02986360
Preoperative Cognitive Screening in Older Spinal Surgical Patients
NCT02922634
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 90 |
| Phase 2 | 107 |
| Phase 3 | 47 |
| Phase 4 | 77 |
Therapeutic Areas
What is open in the Brigham and Women's Hospital pipeline
145 recruiting of 937 indexed (15% open); 608 completed (65%).
Phase mix: 124 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Brigham and Women's Hospital: open-pipeline peers nationwide
Peers matched on 937 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Brigham and Women's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 937 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of Minnesota · 966 trials · 19% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Incyte Corporation · 15% recruiting · 239 trials
- Northwestern University · 15% recruiting · 1,209 trials
- Nationwide Children's Hospital · 15% recruiting · 188 trials
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
Related
What to do with this Brigham and Women's Hospital page
937 registered trials is a research-attention snapshot, not an endorsement of Brigham and Women's Hospital or any single study.
- 145 of Brigham and Women's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition Brigham and Women's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Brigham and Women's Hospital pipeline card: 937 registered trials from official public datasets.Report a data error.